Intrapace Company
%20.jpg)
IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.
%20.jpg)
%20.jpg)
Total Funding:
$192.9M
Headquarters:
San Jose, California, United States
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Technology:
P4 Medicine
Investor Type:
For Profit
Investors Number:
10
Founded Date:
2001-01-01
Industry:
Biotechnology, Health Care, Health Diagnostics